$1.94B Market Cap.
RXRX Market Cap. (MRY)
RXRX Shares Outstanding (MRY)
RXRX Assets (MRY)
Total Assets
$1.45B
Total Liabilities
$413.82M
Total Investments
$5.63M
RXRX Income (MRY)
Revenue
$58.84M
Net Income
-$463.66M
Operating Expense
$492.61M
RXRX Cash Flow (MRY)
CF Operations
-$359.17M
CF Investing
$260.06M
CF Financing
$304.12M
RXRX Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | - | - | 0% | - |
RXRX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,448,598,000 (121.60%) | $653,699,000 (-6.79%) | $701,288,000 (14.90%) | $610,345,000 (104.41%) |
Assets Current | $714,269,000 (63.02%) | $438,137,000 (-23.11%) | $569,814,000 (6.56%) | $534,718,000 (100.69%) |
Assets Non-Current | $734,329,000 (240.66%) | $215,562,000 (63.96%) | $131,474,000 (73.85%) | $75,627,000 (135.25%) |
Goodwill & Intangible Assets | $484,728,000 (447.72%) | $88,499,000 (4100.24%) | $2,107,000 (-3.61%) | $2,186,000 (-12.21%) |
Shareholders Equity | $1,034,782,000 (123.28%) | $463,436,000 (-4.60%) | $485,806,000 (-10.52%) | $542,938,000 (363.19%) |
Property Plant & Equipment Net | $233,213,000 (94.06%) | $120,173,000 (-1.05%) | $121,447,000 (87.64%) | $64,725,000 (149.26%) |
Cash & Equivalents | $597,395,000 (51.32%) | $394,796,000 (-28.37%) | $551,192,000 (92.28%) | $286,668,000 (8.53%) |
Accumulated Other Comprehensive Income | -$7,637,000 (0%) | $0 (0%) | $0 (0%) | -$126,000 (0%) |
Deferred Revenue | $180,532,000 (105.94%) | $87,664,000 (-30.97%) | $126,987,000 (661.91%) | $16,667,000 (0.00%) |
Total Investments | $5,629,000 (-15.09%) | $6,629,000 (-16.30%) | $7,920,000 (-96.70%) | $240,127,000 (7796.32%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $231,446,000 (0%) |
Investments Non-Current | $5,629,000 (-15.09%) | $6,629,000 (-16.30%) | $7,920,000 (-8.77%) | $8,681,000 (185.47%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $49,166,000 (1489.08%) | $3,094,000 (12.39%) | $2,753,000 (-69.71%) | $9,090,000 (5726.92%) |
Trade & Non-Trade Payables | $21,613,000 (446.75%) | $3,953,000 (-13.80%) | $4,586,000 (62.68%) | $2,819,000 (162.48%) |
Accumulated Retained Earnings (Deficit) | -$1,431,283,000 (-47.92%) | -$967,622,000 (-51.30%) | -$639,556,000 (-59.86%) | -$400,080,000 (-87.30%) |
Tax Assets | $1,934,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $16,575,000 (1137.86%) | $1,339,000 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $108,492,000 (114.11%) | $50,672,000 (-0.65%) | $51,005,000 (406.91%) | $10,062,000 (-55.25%) |
Debt Current | $22,220,000 (260.89%) | $6,157,000 (1.79%) | $6,049,000 (6621.11%) | $90,000 (-99.19%) |
Debt Non-Current | $86,272,000 (93.80%) | $44,515,000 (-0.98%) | $44,956,000 (350.82%) | $9,972,000 (-12.63%) |
Total Liabilities | $413,816,000 (117.50%) | $190,263,000 (-11.70%) | $215,482,000 (219.67%) | $67,407,000 (19.17%) |
Liabilities Current | $187,472,000 (101.21%) | $93,171,000 (-7.08%) | $100,265,000 (114.89%) | $46,658,000 (101.99%) |
Liabilities Non-Current | $226,344,000 (133.12%) | $97,092,000 (-15.73%) | $115,217,000 (455.29%) | $20,749,000 (-37.99%) |
RXRX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $58,839,000 (32.00%) | $44,575,000 (11.88%) | $39,843,000 (291.46%) | $10,178,000 (156.89%) |
Cost of Revenue | $45,238,000 (6.22%) | $42,587,000 (-11.78%) | $48,275,000 (0%) | $0 (0%) |
Selling General & Administrative Expense | $178,184,000 (60.78%) | $110,822,000 (35.81%) | $81,599,000 (41.46%) | $57,682,000 (128.37%) |
Research & Development Expense | $314,421,000 (30.34%) | $241,226,000 (54.93%) | $155,696,000 (15.10%) | $135,271,000 (113.63%) |
Operating Expenses | $492,605,000 (39.93%) | $352,048,000 (48.36%) | $237,295,000 (22.98%) | $192,953,000 (117.84%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | -$1,127,000 (72.26%) | -$4,062,000 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$463,661,000 (-41.33%) | -$328,066,000 (-36.99%) | -$239,476,000 (-28.42%) | -$186,479,000 (-114.33%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$463,661,000 (-41.33%) | -$328,066,000 (-36.99%) | -$239,476,000 (-28.42%) | -$186,479,000 (-114.33%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$463,661,000 (-41.33%) | -$328,066,000 (-36.99%) | -$239,476,000 (-28.42%) | -$186,479,000 (-114.33%) |
Weighted Average Shares | $274,207,146 (31.92%) | $207,853,702 (18.41%) | $175,537,487 (40.04%) | $125,348,110 (475.48%) |
Weighted Average Shares Diluted | $274,207,146 (31.92%) | $207,853,702 (18.41%) | $175,537,487 (40.04%) | $125,348,110 (475.48%) |
Earning Before Interest & Taxes (EBIT) | -$464,788,000 (-39.94%) | -$332,128,000 (-38.69%) | -$239,476,000 (-28.42%) | -$186,479,000 (-114.33%) |
Gross Profit | $13,601,000 (584.15%) | $1,988,000 (123.58%) | -$8,432,000 (-182.85%) | $10,178,000 (156.89%) |
Operating Income | -$479,004,000 (-36.83%) | -$350,060,000 (-42.46%) | -$245,727,000 (-34.44%) | -$182,775,000 (-116.01%) |
RXRX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $260,059,000 (2642.62%) | -$10,228,000 (-105.29%) | $193,249,000 (171.11%) | -$271,744,000 (-3009.20%) |
Net Cash Flow from Financing | $304,120,000 (117.02%) | $140,133,000 (-9.21%) | $154,345,000 (-66.34%) | $458,540,000 (86.30%) |
Net Cash Flow from Operations | -$359,174,000 (-24.81%) | -$287,780,000 (-244.55%) | -$83,524,000 (47.34%) | -$158,614,000 (-249.38%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $201,599,000 (227.85%) | -$157,687,000 (-159.78%) | $263,763,000 (835.93%) | $28,182,000 (-85.32%) |
Net Cash Flow - Business Acquisitions and Disposals | $277,104,000 (14927.33%) | $1,844,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $480,000 (-99.79%) | $230,608,000 (199.42%) | -$231,946,000 (-39082.52%) |
Capital Expenditure | -$13,695,000 (-14.55%) | -$11,955,000 (67.74%) | -$37,059,000 (6.88%) | -$39,798,000 (-582.52%) |
Issuance (Repayment) of Debt Securities | -$4,440,000 (-479.63%) | -$766,000 (-751.11%) | -$90,000 (99.30%) | -$12,798,000 (-302.40%) |
Issuance (Purchase) of Equity Shares | $308,560,000 (118.99%) | $140,899,000 (-8.76%) | $154,435,000 (-67.23%) | $471,338,000 (69112.63%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$3,406,000 (-1911.70%) | $188,000 (161.24%) | -$307,000 (0%) | $0 (0%) |
Share Based Compensation | $81,688,000 (52.68%) | $53,503,000 (91.71%) | $27,909,000 (88.04%) | $14,842,000 (245.81%) |
Depreciation Amortization & Accretion | $53,110,000 (63.59%) | $32,465,000 (66.61%) | $19,486,000 (131.84%) | $8,405,000 (113.16%) |
RXRX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 23.10% (413.33%) | 4.50% (121.23%) | -21.20% (-121.20%) | 100.00% (0.00%) |
Profit Margin | -788.00% (-7.07%) | -736.00% (-22.46%) | -601.00% (67.20%) | -1832.20% (16.57%) |
EBITDA Margin | -699.70% (-4.08%) | -672.30% (-21.77%) | -552.10% (68.44%) | -1749.60% (16.55%) |
Return on Average Equity (ROAE) | -72.90% (0.00%) | -72.90% (-37.29%) | -53.10% (-10.40%) | -48.10% (-191.44%) |
Return on Average Assets (ROAA) | -52.90% (-3.93%) | -50.90% (-44.60%) | -35.20% (-5.71%) | -33.30% (23.45%) |
Return on Sales (ROS) | -789.90% (-6.01%) | -745.10% (-23.98%) | -601.00% (67.20%) | -1832.20% (16.57%) |
Return on Invested Capital (ROIC) | -220.30% (27.17%) | -302.50% (-83.56%) | -164.80% (-31.73%) | -125.10% (54.39%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -4 (35.91%) | -6.24 (-10.09%) | -5.67 (50.69%) | -11.5 |
Price to Sales Ratio (P/S) | 31.5 (-31.48%) | 45.98 (35.35%) | 33.97 (-83.90%) | 210.97 |
Price to Book Ratio (P/B) | 1.87 (-59.36%) | 4.61 (53.22%) | 3.01 (-43.59%) | 5.33 |
Debt to Equity Ratio (D/E) | 0.4 (-2.68%) | 0.41 (-7.43%) | 0.44 (258.06%) | 0.12 (145.26%) |
Earnings Per Share (EPS) | -1.69 (-6.96%) | -1.58 (-16.18%) | -1.36 (8.72%) | -1.49 (62.66%) |
Sales Per Share (SPS) | 0.21 (0.47%) | 0.21 (-5.73%) | 0.23 (180.25%) | 0.08 (-55.49%) |
Free Cash Flow Per Share (FCFPS) | -1.36 (5.69%) | -1.44 (-109.90%) | -0.69 (56.60%) | -1.58 (32.70%) |
Book Value Per Share (BVPS) | 3.77 (69.24%) | 2.23 (-19.44%) | 2.77 (-36.09%) | 4.33 (145.73%) |
Tangible Assets Book Value Per Share (TABVPS) | 3.52 (29.28%) | 2.72 (-31.73%) | 3.98 (-17.91%) | 4.85 (-64.31%) |
Enterprise Value Over EBIT (EV/EBIT) | -3 (40.00%) | -5 (-25.00%) | -4 (69.23%) | -13 |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.88 (35.26%) | -6 (-24.88%) | -4.8 (65.79%) | -14.04 |
Asset Turnover | 0.07 (-2.90%) | 0.07 (16.95%) | 0.06 (227.78%) | 0.02 (-10.00%) |
Current Ratio | 3.81 (-18.99%) | 4.7 (-17.24%) | 5.68 (-50.41%) | 11.46 (-0.65%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$372,869,000 (-24.40%) | -$299,735,000 (-148.57%) | -$120,583,000 (39.23%) | -$198,412,000 (-287.30%) |
Enterprise Value (EV) | $1,599,115,031 (-11.05%) | $1,797,803,156 (70.10%) | $1,056,928,794 (-57.73%) | $2,500,641,340 |
Earnings Before Tax (EBT) | -$464,788,000 (-39.94%) | -$332,128,000 (-38.69%) | -$239,476,000 (-28.42%) | -$186,479,000 (-114.33%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$411,678,000 (-37.38%) | -$299,663,000 (-36.22%) | -$219,990,000 (-23.54%) | -$178,074,000 (-114.38%) |
Invested Capital | $287,495,000 (124.77%) | $127,905,000 (29.55%) | $98,729,000 (-65.35%) | $284,895,000 (808.55%) |
Working Capital | $526,797,000 (52.71%) | $344,966,000 (-26.53%) | $469,549,000 (-3.79%) | $488,060,000 (100.57%) |
Tangible Asset Value | $963,870,000 (70.54%) | $565,200,000 (-19.16%) | $699,181,000 (14.97%) | $608,159,000 (105.39%) |
Market Capitalization | $1,937,692,031 (-9.28%) | $2,135,905,156 (46.15%) | $1,461,474,794 (-49.51%) | $2,894,851,340 |
Average Equity | $636,235,250 (41.34%) | $450,135,250 (-0.25%) | $451,246,250 (16.33%) | $387,913,250 (334.70%) |
Average Assets | $877,201,250 (36.07%) | $644,647,250 (-5.19%) | $679,913,750 (21.44%) | $559,871,000 (179.92%) |
Invested Capital Average | $210,973,000 (92.16%) | $109,791,250 (-24.46%) | $145,338,750 (-2.53%) | $149,103,750 (370.15%) |
Shares | 286,640,833 (32.32%) | 216,623,241 (14.28%) | 189,555,745 (12.17%) | 168,993,073 (5.68%) |
